TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events

TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Other Events
Item 8.01

On June 1, 2020, Tonix Pharmaceuticals Holding Corp., a Nevada corporation, (the “Company”), announced that it entered into an agreement with FUJIFILM Diosynth Biotechnologies for manufacturing and development services related to the Company’s COVID-19 vaccine candidate, TNX-1800. A copy of the press release which discusses this matter is attached hereto as Exhibit 99.01 and is incorporated herein by reference.

99.01 Press Release of the Company, date June 1, 2020


Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 ex99-01.htm PRESS RELEASE   Tonix Pharmaceuticals Holding Corp. 8-K   Exhibit 99.01   Tonix Pharmaceuticals Announces FUJIFILM Diosynth Biotechnologies to be Manufacturing Partner for COVID-19 Vaccine Candidate TNX-1800   Collaboration includes Development of Manufacturing Processes and to Supply Clinical Trial Material to Support Tonix’s Development of TNX-1800 NEW YORK,…
To view the full exhibit click here

An ad to help with our costs